Clinical studies recruiting near Albacete

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Complejo Hospitalario Universitario de Albacete · Spanish Oncology Genito-Urinary Group · NCT06724159 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · H. Univers. De Albacete · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Phase N/A · Complejo Hospitalario Universitario de Albacete · Biobizkaia Health Research Institute · NCT07240038 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Complejo Hospitalario Universitario de Albacete · Hoffmann-La Roche · NCT07284121 RCT to Analyze the Efficacy of a Spanish Healthcare ministRy Based In InTervention to Reduce Frailty Status in Prefrail
NA · Complejo Hospitalario Universitario de Albacete · Complejo Hospitalario Universitario de Albacete · NCT05002439 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Hospital General Universitario de Albacete · Kura Oncology, Inc. · NCT07007312 Thoracic Tumours Register
Phase N/A · Complejo Hospitalario Universitario de Albacete · Spanish Lung Cancer Group · NCT02941458 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NA · H Albacete · PETHEMA Foundation · NCT04179929 Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Phase N/A · Hospital General Universitario de Albacete · Fundación EPIC · NCT06863155 Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Phase 2/Phase 3 · Corxel Investigational Site · Corxel Pharmaceuticals · NCT06990867 Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Phase 3 · Complejo Hospitalario de Albacete · PETHEMA Foundation · NCT07478991 A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
Phase 3 · Hospital Universitario Nuestra Señora del Perpétuo Socorro · Fundación para la Investigación del Hospital Clínico de Vale · NCT06578078 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2 · Hosp. Gral. de Albacete · Intra-Cellular Therapies, Inc. · NCT06540833 Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
Phase N/A · Albacete University Hospital Complex · Hospital Universitario 12 de Octubre · NCT06896266 Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · Private Practice · Inmunotek S.L. · NCT04891237 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU
NA · Hospital General de Albacete · Hospital Clinico Universitario de Santiago · NCT06322719 Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Phase N/A · Hospital General Universitario de Albacete · Manuel Monreal · NCT02832245 Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
Phase 3 · HOSPITAL UNIVERSITARIO DE ALBACETE-Servicio de Hematologia · The Lymphoma Academic Research Organisation · NCT06284122 Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions
Phase 4 · Complejo Hospitalario Universitario de Albacete (ICU) · Hospital Universitario de Gran Canaria Doctor Negrín · NCT04545242 DESTINY Breast Respond HER2-(Ultra)Low Europe
Phase N/A · Hospital Clinico Universitario de Albacete · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05945732 A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Phase 1/Phase 2 · Hospital General Universitario De Albacete · Sumitomo Pharma America, Inc. · NCT04988555 A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Phase N/A · Complejo Hospitalario Universitario de Albacete · Spanish Breast Cancer Research Group · NCT02819882 Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Phase N/A · Hospital General Universitario de Albacete · Hospital Universitari Vall d'Hebron Research Institute · NCT07159750 NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Phase 3 · Hospital General Universitario de Albacete · PETHEMA Foundation · NCT05558319 Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subje
Phase 3 · Complejo Hospitalario Universitario de Albacete · Greenwich LifeSciences, Inc. · NCT05232916 Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients
Phase 2 · Complejo Hospitalario de Albacete · PETHEMA Foundation · NCT07507760 Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Phase 2 · Hospital General Universitario de Albacete · Fundación GECP · NCT07242547 The Impact of Radiotherapy on Oligometastatic Cancer
Phase N/A · Complejo Hospitalario Universitario Albacete · Institut Investigacio Sanitaria Pere Virgili · NCT05933876

Look up another city

Look up another condition